Blockchain Registration Transaction Record
New Policy Paper Raises Concerns About 340B Drug Pricing Program Integrity
ADAP Advocacy's latest policy paper questions the integrity of the 340B Drug Pricing Program, emphasizing the need for reforms to prevent potential failures. Learn more about the concerns raised and the importance of transparency and oversight in maintaining the program's effectiveness.

This news matters because it sheds light on potential flaws in a crucial federally sponsored drug program, impacting the healthcare system and patient access to medications. The comparison to the financial crisis underscores the urgency for reforms to ensure the program's sustainability and effectiveness.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xd18f031a59811a135a906e805d8871a8161364ea68abd9281b745d2051bfb813 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | riftBT_q-97a691ab81f964379c0c783e611c3a01 |